Moderna (MRNA) Asset Utilization Ratio (2019 - 2026)
Moderna (MRNA) reported Asset Utilization Ratio of 0.19 for Q1 2026, down 19.44% year-over-year from 0.23 in Q1 2025, and up 17.56% quarter-over-quarter from 0.16 in Q4 2025.
Moderna (MRNA) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Moderna (MRNA) has 8 years of Asset Utilization Ratio data on file, last reported at 0.19 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.19, down 19.44% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.19 (down 19.44% YoY), and the FY2025 annual result was 0.15, down 26.11% from the prior year.
- Asset Utilization Ratio grew to 0.19 in Q1 2026 per MRNA's latest filing, from 0.16 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.86 in Q1 2022 and troughed at 0.16 in Q4 2025.
- A 5-year average of 0.43 and a median of 0.32 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio surged 216.97% in 2022, then plunged 51.35% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.74 in 2022, then tumbled by 51.27% to 0.36 in 2023, then slumped by 41.43% to 0.21 in 2024, then fell by 24.99% to 0.16 in 2025, then gained by 17.56% to 0.19 in 2026.
- Business Quant data shows MRNA's Asset Utilization Ratio at 0.19 in Q1 2026, 0.16 in Q4 2025, and 0.18 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.60 |
| Dec 31, 2022 | 0.74 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.86 |
| Mar 31, 2022 | 0.86 |
| Dec 31, 2021 | 0.81 |
| Sep 30, 2021 | 0.64 |
| Jun 30, 2021 | 0.49 |